Vinorelbine Tartrate
Who holds supplier records for Vinorelbine Tartrate? 4 organisations hold a current record for Vinorelbine Tartrate: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (1), Belgium (1) and France (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Vinorelbine Tartrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/vinorelbine-tartrate
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Vinorelbine Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- HUBEI HONCH PHARMACEUTICAL CO LTDCEP Company GMP cert on recordActive DMF 26091 · latest filing Dec 2013
- Jiangsu Hansoh Pharmaceutical Group Company LimitedChinaCEP Company GMP cert on recordActive DMF 31480, 16011 · latest filing Apr 2017
- MINAKEM HIGH POTENTBelgiumCEPActive DMF 14619 · latest filing Dec 1999
- PIERRE FABRE MEDICAMENTFranceCEPActive DMF 9477 · latest filing Nov 1991
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Vinorelbine Tartrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HUBEI HONCH PHARMACEUTICAL CO., LTD. Huanggang | CN | CEP 2009-394 - Rev 06 Vinorelbine tartrate | Apr 2024 | Inspected Feb 2025 Switzerland |
| JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. Lianyungang City | CN | R1-CEP 2017-075 - Rev 00 Vinorelbine tartrate | Feb 2023 | — |
| PIERRE FABRE MEDICAMENT Gaillac | FR | R1-CEP 2004-297 - Rev 05 Vinorelbine tartrate | Feb 2020 | — |
| MINAKEM HIGH POTENT Mont-Saint-Guibert | BE | R1-CEP 2011-342 - Rev 00 Vinorelbine tartrate | Aug 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Vinorelbine Tartrate are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- SYNBIAS PHARMA LTDAlso filed as SYNBIAS PHARMA AGSwitzerland · Inactive DMF 21929, 28221 · filed May 2014
- China · Inactive DMF 25783 · filed Feb 2012
- China · Inactive DMF 25203 · filed Jul 2011
- ALP PHARM BEIJING CO LTDInactive DMF 23951 · filed Jun 2010
- India · Inactive DMF 20158 · filed Feb 2009
- EXOPHARM CO LTDInactive DMF 19094 · filed Jan 2006
- Argentina · Inactive DMF 16706 · filed Jul 2003
- China · Inactive DMF 15956 · filed Apr 2002
- HOECHST MARION ROUSSEL SAInactive DMF 8097 · filed Jun 1989
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Vinorelbine Tartrate is a semi-synthetic vinca alkaloid used to treat certain types of cancer, including non-small cell lung cancer. It works by inhibiting mitosis, thereby preventing the multiplication of cancer cells.
Chemical identity
- IUPAC name
- bis((2R,3R)-2,3-dihydroxybutanedioic acid);methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
- Canonical SMILES
- CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- InChIKey
- CILBMBUYJCWATM-PYGJLNRPSA-N
- Synonyms
- Navelbine API, liposomal vinorelbine tartrate, tlc-178, tlc178, vinorelbine (as tartrate), vinorelbine ditartrate, vinorelbine liposomal, vinorelbine tartrate (1:2)
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Vinca Alkaloid
- Chemical structure
- Vinca Alkaloids
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Vinorelbine Tartrate?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Vinorelbine Tartrate: HUBEI HONCH PHARMACEUTICAL CO LTD, Jiangsu Hansoh Pharmaceutical Group Company Limited (China), MINAKEM HIGH POTENT (Belgium) and PIERRE FABRE MEDICAMENT (France). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Vinorelbine Tartrate Drug Master Files are active?
HUBEI HONCH PHARMACEUTICAL CO LTD (DMF 26091), Jiangsu Hansoh Pharmaceutical Group Company Limited (DMF 31480, 16011), MINAKEM HIGH POTENT (DMF 14619) and PIERRE FABRE MEDICAMENT (DMF 9477). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Vinorelbine Tartrate records mean?
9 organisations have only inactive Type II DMFs for Vinorelbine Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Vinorelbine Tartrate have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Vinorelbine Tartrate on the EDQM register, including HUBEI HONCH PHARMACEUTICAL CO., LTD. Huanggang (CN), JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. Lianyungang City (CN), PIERRE FABRE MEDICAMENT Gaillac (FR) and MINAKEM HIGH POTENT Mont-Saint-Guibert (BE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Vinorelbine Tartrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Vinorelbine Tartrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.